- CA$27.77m
- CA$18.34m
- CA$45.12m
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue
Brief: Medipharm Labs To Enter New Market With Costa Rica Supply Agreement
MediPharm Labs Q3 revenue up 17% on medical cannabis demand
Brief: Medipharm Labs Says Annual & Special Shareholders Meeting Yet to Occur
Brief: Apollo Technology Capital Says Its Board Nominees Constitute New Board For Medipharm Labs
Brief: Glass Lewis Recommends Shareholders Vote The GREEN Proxy FOR ALL MediPharm Director Nominees
Brief: Medipharm Labs Says Court Dismisses Application Against Medipharm Labs By Apollo Technology Capital
Brief: Medipharm Labs Closes $4.5 Million Sale Of Hope, Bc Facility And Announces Plans To Expand EU Gmp Cultivation Capacity At Napanee Facility
Brief: MediPharm Labs Corp Commences Legal Proceedings Against Apollo Technology Capital
Brief: MediPharm Labs Begins Production Of First Order For International Expansion Of Novel Cannabis Metered Dose Portfolio In EU And United Kingdom
Brief: Apollo Technology Capital Corporation To Nominate Six Directors To Medipharm Labs' Board
Brief: MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health
Brief: Medipharm Labs and Brazil's Laboratório Teuto Enter Landmark Commercial Agreement
Founder Keith Strachan
Brief: MediPharm Labs Provides Update On German Cannabis Legalization
Brief: Miriam McDonald Resigns From MediPharm Labs Board